piracetam has been researched along with Adenocystic Carcinoma in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakata, S | 1 |
| Saeki, S | 1 |
| Terasaki, Y | 1 |
| Natori, Y | 1 |
| Fujii, K | 1 |
1 other study available for piracetam and Adenocystic Carcinoma
| Article | Year |
|---|---|
A Favorable Response to Levetiracetam in a Patient with Metastatic Adenoid Cystic Carcinoma.
Topics: Anticonvulsants; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenoid Cystic; Cisplati | 2018 |